Product information
From Health Canada
Current status:
Cancelled Pre Market
Current status date:
2021-07-09
Original market date: See footnote 1
Product name:
AMPICILLIN FOR INJECTION
DIN:
02227037 Electronic product monograph is not available
Company:
FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada
M9W 0C8
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous , Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.16.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01CA01 AMPICILLIN
Active ingredient group (AIG) number:See footnote5
0105872008
Active ingredient(s) | Strength |
---|---|
AMPICILLIN (AMPICILLIN SODIUM) | 125 MG / VIAL |